-
35th listing on Euronext in 2026
-
The company raised €2 million
-
Market capitalisation at IPO is €5.3 million
Milan – 26 June 2026 – Euronext today congratulates OPT on its listing on Euronext Growth Milan.
OPT designs and delivers high-value services for healthcare (Healthcare High Value-Added Services, or HHVAS), in the clinical and organisational field, aimed at both public and private healthcare systems, and sponsored by pharmaceutical companies.
The listing of OPT represents Euronext’s 35th listing this year. In the placement phase, OPT raised €2 million including the potential exercise of the over-allotment option. Excluding the exercise of the over-allotment option, the total amount raised will be €1.8 million.
The free float at the time of admission is 33.68%, and the market capitalisation at IPO amounts to €5.3 million (€5.5 million, assuming the full exercise of the over-allotment option).
Davide Lucano, Chief Executive Officer of OPT, said: "Healthcare High Value-Added Services are becoming an increasingly important component in the evolution of modern healthcare systems, as they enable the structured integration of the needs of various stakeholders, including hospitals, pharmaceutical and medtech companies, patients, and institutions, throughout the entire care journey. Our work focuses precisely on this intersection: supporting the implementation of more efficient clinical and organisational models, promoting the appropriate adoption of therapies, enhancing the monitoring capabilities of care pathways, and contributing to the generation of evidence that is valuable to all stakeholders involved. In this context, OPT acts as an operational partner to the healthcare system, with the goal of making care pathways more coordinated, measurable, and sustainable, while simultaneously improving the patient experience and the overall quality of care."
Giuliano Rizzi, member of the board of directors of OPT, Oreste Pitocchi, founder and member of the board of directors of OPT, Davide Lucano, CEO of OPT and Giacomo Andreoli, chairman of the board of directors of OPT
CONTACTS
| ANALYSTS & INVESTORS – ir@euronext.com | ||
| Investor Relations | Judith Stein | +33 6 15 23 91 97 |
| Margaux Kurver | +33 6 84 16 85 03 | |
| MEDIA – mediateam@euronext.com | ||
| Europe | Andrea Monzani | +33 1 7048 24 45 |
| Sandra Machado | +351 917 776 897 | |
| Belgium | Marianne Aalders | +32 26 20 15 01 |
| France, Corporate | Flavio Bornancin-Tomasella | +33 1 70 48 24 45 |
| Greece | Ioulia Zafolia | +30 694 570 1070 |
| Ireland | Catalina Augspach | +39 02 72 42 62 13 |
| Italy | Ester Russom | +39 02 72 42 67 56 |
| The Netherlands | Marianne Aalders | +31 20 721 41 33 |
| Norway | Cathrine Lorvik Segerlund | +47 41 69 59 10 |
| Portugal | Sandra Machado | +351 91 777 68 97 |